Related Experiment Video
Updated: May 11, 2026

Bone Marrow Transplantation Platform to Investigate the Role of Dendritic Cells in Graft-versus-Host Disease
Published on: March 17, 2020
Chronic granulomatous disease: overview and hematopoietic stem cell transplantation
Elizabeth M Kang1, Betty E Marciano, SukSee DeRavin
1Laboratory of Host Defenses, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. ekang@niaid.nih.gov
Insights
Chronic granulomatous disease (CGD) causes significant illness and death. Bone marrow transplantation is an increasingly viable, curative option for CGD patients, despite its risks.
Area of Science:
- Immunology
- Hematology
- Genetics
Background:
- Chronic granulomatous disease (CGD) is a rare inherited disorder of the immune system.
- CGD leads to severe, recurrent infections and inflammatory conditions, causing significant morbidity and mortality.
- Management of CGD is challenging due to unpredictable disease course and complications.
Purpose of the Study:
- To review the complications of CGD, including infections and autoimmune disorders.
- To discuss current management strategies for CGD complications.
- To evaluate the role and status of allogeneic bone marrow transplantation as a curative therapy for CGD.
Main Methods:
- Literature review of CGD complications and their management.
- Analysis of the current status and outcomes of bone marrow transplantation in CGD patients.
- Discussion of the risks and benefits associated with bone marrow transplantation for CGD.
Main Results:
- CGD is associated with life-threatening infections and debilitating autoimmune/inflammatory conditions.
- Effective management of CGD complications is crucial for improving patient outcomes.
- Bone marrow transplantation has emerged as a potentially curative treatment option for CGD, with improving success rates.
Conclusions:
- Despite significant challenges, bone marrow transplantation offers a curative pathway for CGD.
- Careful patient selection and management are essential for successful transplantation outcomes.
- Further research and advancements in transplantation techniques are vital for expanding access to this therapy for CGD patients.
Abstract:
Chronic granulomatous disease (CGD) still causes significant morbidity and mortality. The difficulty in considering high-risk yet curative treatments, such as allogeneic bone marrow transplantation, lies in the unpredictable courses of both CGD and bone marrow transplantation in different patients. Some patients with CGD can have frequent infections, granulomatous or autoimmune disorders necessitating immunosuppressive therapy, or both but also experience long periods of relative good health. However, the risk of death is clearly higher in patients with CGD of all types, and the complications of CGD short of death can still cause significant morbidity. Therefore, with recent developments and improvements, bone marrow transplantation, previously considered an experimental or high-risk procedure, has emerged as an important option for patients with CGD. We will discuss the complications of CGD that result in significant morbidity and mortality, particularly the most common infections and autoimmune/inflammatory complications, as well as their typical management. We will then discuss the status of bone marrow transplantation.
Related Concept Videos
Multipotency of Hematopoietic Stem Cells
Regulation of Hematopoietic Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

